<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE Annotation PUBLIC "-//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN" "../GENIAtypes/GENIA_event_20.dtd">
<Annotation created="29/03/2006" creator="Noriko Katsu" annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=9416887">
<PubmedArticleSet>
<PubmedArticle>
<MedlineCitation>
<PMID>9416887</PMID>
<Article>
<ArticleTitle>
<sentence id="S1"><term sem="Organic_compound_other" id="T1" lex="cyclosporin_A">Cyclosporin A</term> inhibits <term sem="Other" id="T2" lex="monocyte_tissue_factor_activation">monocyte <term sem="Protein_family_or_group" id="T3" lex="tissue_factor">tissue factor</term> activation</term> in <term sem="Multicellular_organism_natural" id="T4" lex="cardiac_transplant_recipient">cardiac transplant recipients</term>.</sentence>
<event id="E1">
<type class="Positive_regulation" />
<theme idref="T3" />
<clue>Cyclosporin A inhibits <clueLoc>monocyte</clueLoc> tissue factor <clueType>activation</clueType> in cardiac transplant recipients.</clue>
</event>
<event id="E2">
<type class="Negative_regulation" />
<theme idref="E1" />
<cause idref="T1" />
<clue>Cyclosporin A <clueType>inhibits</clueType> monocyte tissue factor activation <clueLoc>in cardiac transplant recipients</clueLoc>.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2">BACKGROUND: <term sem="Other" id="T5" lex="fibrin_deposition"><term sem="Protein_molecule" id="A2">Fibrin</term> deposition</term> and <term sem="Other" id="T6" lex="thrombosis">thrombosis</term> have been implicated in both <term sem="Other" id="T7" lex="allograft_rejection"><term sem="Body_region" id="A3">allograft</term> rejection</term> and <term sem="Other" id="T8" lex="vasculopathy">vasculopathy</term> after <term sem="Other" id="T9" lex="cardiac_transplantation">cardiac transplantation</term>.</sentence>
<event id="E3">
<type class="Localization" />
<theme idref="A2" />
<clue>BACKGROUND: Fibrin <clueType>deposition</clueType> and thrombosis have been implicated in both allograft rejection and vasculopathy after cardiac transplantation.</clue>
</event>
<event id="E4">
<type class="Negative_regulation" />
<theme idref="A3" />
<clue>BACKGROUND: Fibrin deposition and thrombosis have been implicated in both allograft <clueType>rejection</clueType> and vasculopathy after cardiac transplantation.</clue>
</event>
<sentence id="S3">Because <term sem="Cell_natural" id="T10" lex="monocyte">monocytes</term> play a pivotal role in the pathophysiology of <term sem="Other" id="T11" lex="intravascular_coagulation">intravascular coagulation</term> activation through their ability to synthesize <term sem="Protein_family_or_group" id="T12" lex="tissue_factor">tissue factor</term> (<term sem="Protein_family_or_group" id="T13" lex="TF">TF</term>), we asked (1) whether <term sem="Other" id="T14" lex="monocyte_TF_activation">monocyte <term sem="Protein_family_or_group" id="T15" lex="TF">TF</term> activation</term> occurs in <term sem="Multicellular_organism_natural" id="T16" lex="cardiac_transplant_recipient">cardiac transplant recipients</term> and (2) whether <term sem="Other" id="T17" lex="monocyte_TF_expression">monocyte <term sem="Other" id="T18" lex="TF_expression"><term sem="Protein_family_or_group" id="T19" lex="TF">TF</term> expression</term></term> is affected by treatment with <term sem="Organic_compound_other" id="T20" lex="cyclosporin_A">cyclosporin A</term> (<term sem="Organic_compound_other" id="T21" lex="CsA">CsA</term>).</sentence>
<event id="E5">
<type class="Positive_regulation" />
<theme idref="T11" />
<cause idref="E6" />
<clue>Because monocytes play a pivotal role in the pathophysiology of intravascular coagulation <clueType>activation</clueType> <linkCause>through</linkCause> their ability to synthesize tissue factor (TF), we asked (1) whether monocyte TF activation occurs in cardiac transplant recipients and (2) whether monocyte TF expression is affected by treatment with cyclosporin A (CsA).</clue>
</event>
<event id="E6">
<type class="Gene_expression" />
<theme idref="T12" />
<clue>Because <clueLoc>monocytes</clueLoc> play a pivotal role in the pathophysiology of intravascular coagulation activation through their ability to <clueType>synthesize</clueType> tissue factor (TF), we asked (1) whether monocyte TF activation occurs in cardiac transplant recipients and (2) whether monocyte TF expression is affected by treatment with cyclosporin A (CsA).</clue>
</event>
<event id="E7">
<type class="Regulation" />
<theme idref="E5" />
<cause idref="T10" />
<clue>Because monocytes <clueType>play a pivotal role</clueType> <linkTheme>in</linkTheme> the pathophysiology of intravascular coagulation activation through their ability to synthesize tissue factor (TF), we asked (1) whether monocyte TF activation occurs in cardiac transplant recipients and (2) whether monocyte TF expression is affected by treatment with cyclosporin A (CsA).</clue>
</event>
<event uncertainty="doubtful" id="E8">
<type class="Positive_regulation" />
<theme idref="E33" />
<clue>Because monocytes play a pivotal role in the pathophysiology of intravascular coagulation activation through their ability to synthesize tissue factor (TF), we asked (1) whether monocyte TF activation <clueType>occurs</clueType> <clueLoc>in cardiac transplant recipients</clueLoc> and (2) whether monocyte TF expression is affected by treatment with cyclosporin A (CsA).</clue>
</event>
<event id="E33">
<type class="Positive_regulation" />
<theme idref="T15" />
<clue>Because monocytes play a pivotal role in the pathophysiology of intravascular coagulation activation through their ability to synthesize tissue factor (TF), we asked (1) whether <clueLoc>monocyte</clueLoc> TF <clueType>activation</clueType> occurs in cardiac transplant recipients and (2) whether monocyte TF expression is affected by treatment with cyclosporin A (CsA).</clue>
</event>
<event uncertainty="doubtful" id="E9">
<type class="Regulation" />
<theme idref="E10" />
<cause idref="T21" />
<clue>Because monocytes play a pivotal role in the pathophysiology of intravascular coagulation activation through their ability to synthesize tissue factor (TF), we asked (1) whether monocyte TF activation occurs in cardiac transplant recipients and (2) whether monocyte TF expression is <clueType>affected</clueType> <linkCause>by</linkCause> treatment with cyclosporin A (CsA).</clue>
</event>
<event id="E10">
<type class="Gene_expression" />
<theme idref="T19" />
<clue>Because monocytes play a pivotal role in the pathophysiology of intravascular coagulation activation through their ability to synthesize tissue factor (TF), we asked (1) whether monocyte TF activation occurs in cardiac transplant recipients and (2) whether <clueLoc>monocyte</clueLoc> TF <clueType>expression</clueType> is affected by treatment with cyclosporin A (CsA).</clue>
</event>
<sentence id="S4">METHODS AND RESULTS: We measured levels of <term sem="Other" id="T22" lex="TF_activity"><term sem="Protein_family_or_group" id="T23" lex="TF">TF</term> activity</term> in <term sem="Cell_natural" id="T24" lex="peripheral_blood_mononuclear_cell">peripheral blood mononuclear cells</term> and <term sem="Cell_natural" id="T25" lex="highly_purified_monocyte/macrophage">highly purified <term sem="Cell_natural" id="T26" lex="monocyte">monocytes</term>/macrophages</term> from 10 consecutive <term sem="Multicellular_organism_natural" id="T27" lex="cardiac_transplant_recipient">cardiac transplant recipients</term> and 10 <term sem="Multicellular_organism_natural" id="T28" lex="healthy_control_subject">healthy control subjects</term>.</sentence>
<sentence id="S5"><term sem="Other" id="T29" lex="TF_activity"><term sem="Protein_family_or_group" id="T30" lex="TF">TF</term> activity</term> generated by both <term sem="Cell_cultured" id="T31" lex="unstimulated_cell">unstimulated</term> and <term sem="Cell_cultured" id="T32" lex="endotoxin-stimulated_cell"><term sem="Cell_cultured" id="A5"><term sem="Organic_compound_other" id="A1">endotoxin</term>-stimulated</term> <term sem="Cell_cultured" id="A6">cells</term></term> was significantly higher in <term sem="Multicellular_organism_natural" id="T33" lex="transplant_recipient">transplant recipients</term> than in <term sem="Multicellular_organism_natural" id="T34" lex="control_subject">control subjects</term> (P&lt;.05).</sentence>
<event id="E13">
<type class="Positive_regulation" />
<theme idref="T30" />
<cause idref1="A6" idref="T31" />
<clue>TF activity <clueType>generated</clueType> <clueLoc>by</clueLoc> both <clueLoc>unstimulated</clueLoc> and endotoxin-stimulated <clueLoc>cells</clueLoc> was significantly higher in transplant recipients than in control subjects (P&lt;.05).</clue>
</event>
<event id="E14">
<type class="Positive_regulation" />
<theme idref="T29" />
<clue>TF activity <clueType>generated</clueType> <clueLoc>by</clueLoc> both unstimulated and <clueLoc>endotoxin-stimulated cells</clueLoc> was significantly higher in transplant recipients than in control subjects (P&lt;.05).</clue>
</event>
<event id="E40">
<type class="Physiological_process" />
<theme idref="A6" />
<cause idref="A1" />
<clue>TF activity generated by both unstimulated and endotoxin-<clueType>stimulated</clueType> cells was significantly higher in transplant recipients than in control subjects (P&lt;.05).</clue>
</event>
<sentence id="S6">Increased <term sem="Other" id="T35" lex="monocyte_TF_expression">monocyte <term sem="Other" id="T36" lex="TF_expression"><term sem="Protein_family_or_group" id="T37" lex="TF">TF</term> expression</term></term> in <term sem="Multicellular_organism_natural" id="T38" lex="transplant_recipient">transplant recipients</term> was shown to be adversely affected by treatment with <term sem="Organic_compound_other" id="T39" lex="CsA">CsA</term>: <term sem="Other" id="T40" lex="TF_induction"><term sem="Protein_family_or_group" id="T41" lex="TF">TF</term> induction</term> was markedly reduced by <term sem="Organic_compound_other" id="T42" lex="CsA">CsA</term> serum concentrations reaching peak <term sem="Other" id="T43" lex="CsA_drug_level"><term sem="Organic_compound_other" id="T44" lex="CsA">CsA</term> drug levels</term>.</sentence>
<event id="E12">
<type class="Positive_regulation" />
<theme idref="E15" />
<clue><clueType>Increased</clueType> monocyte TF expression in transplant recipients was shown to be adversely affected by treatment with CsA: TF induction was markedly reduced by CsA serum concentrations reaching peak CsA drug levels.</clue>
</event>
<event id="E15">
<type class="Gene_expression" />
<theme idref="T37" />
<clue>Increased <clueLoc>monocyte</clueLoc> TF <clueType>expression</clueType> <clueLoc>in transplant recipients</clueLoc> was shown to be adversely affected by treatment with CsA: TF induction was markedly reduced by CsA serum concentrations reaching peak CsA drug levels.</clue>
</event>
<event id="E16">
<type class="Negative_regulation" />
<theme idref="E12" />
<cause idref="T39" />
<clue>Increased monocyte TF expression in transplant recipients was shown to be <clueType>adversely affected</clueType> by treatment <linkCause>with</linkCause> CsA: TF induction was markedly reduced by CsA serum concentrations reaching peak CsA drug levels.</clue>
</event>
<event id="E17">
<type class="Negative_regulation" />
<theme idref="E34" />
<cause idref="T42" />
<clue>Increased monocyte TF expression in transplant recipients was shown to be adversely affected by treatment with CsA: TF induction was markedly <clueType>reduced</clueType> <linkCause>by</linkCause> CsA serum concentrations reaching peak CsA drug levels.</clue>
</event>
<event id="E34">
<type class="Positive_regulation" />
<theme idref="T41" />
<clue>Increased monocyte TF expression in transplant recipients was shown to be adversely affected by treatment with CsA: TF <clueType>induction</clueType> was markedly reduced by CsA serum concentrations reaching peak CsA drug levels.</clue>
</event>
<sentence id="S7">Inhibition of <term sem="Other" id="T45" lex="TF_induction"><term sem="Protein_family_or_group" id="T46" lex="TF">TF</term> induction</term> in the presence of high <term sem="Organic_compound_other" id="T47" lex="CsA">CsA</term> blood concentrations was also observed when stimulation of <term sem="Cell_natural" id="A8">cells</term> was performed with <term sem="Protein_molecule" id="T48" lex="interferon-gamma">interferon-gamma</term> or <term sem="Protein_molecule" id="T49" lex="interleukin-1beta">interleukin-1beta</term>.</sentence>
<event id="E18">
<type class="Negative_regulation" />
<theme idref="E35" />
<cause idref="T47" />
<clue><clueType>Inhibition</clueType> <linkTheme>of</linkTheme> TF induction <linkCause>in the presence of</linkCause> high CsA <clueLoc>blood</clueLoc> concentrations was also observed when stimulation of cells was performed with interferon-gamma or interleukin-1beta.</clue>
</event>
<event id="E35">
<type class="Positive_regulation" />
<theme idref="T46" />
<clue>Inhibition of TF <clueType>induction</clueType> in the presence of high CsA blood concentrations was also observed when stimulation of cells was performed with interferon-gamma or interleukin-1beta.</clue>
</event>
<event id="E19">
<type class="Physiological_process" />
<theme idref="A8" />
<cause idref="T48" />
<clue>Inhibition of TF induction in the presence of high CsA blood concentrations was also observed when <clueType>stimulation</clueType> <linkTheme>of</linkTheme> cells was performed <linkCause>with</linkCause> interferon-gamma or interleukin-1beta.</clue>
</event>
<event id="E20">
<type class="Physiological_process" />
<theme idref="A8" />
<cause idref="T49" />
<clue>Inhibition of TF induction in the presence of high CsA blood concentrations was also observed when <clueType>stimulation</clueType> <linkTheme>of</linkTheme> cells was performed <linkCause>with</linkCause> interferon-gamma or interleukin-1beta.</clue>
</event>
<event id="E21">
<type class="Negative_regulation" />
<theme idref="E35" />
<cause idref="E19" />
<clue>Inhibition of TF induction in the presence of high CsA blood concentrations was also observed <linkCause>when</linkCause> stimulation of cells was performed with interferon-gamma or interleukin-1beta.</clue>
<comment>NO CLUETYPE</comment>
</event>
<event id="E22">
<type class="Negative_regulation" />
<theme idref="E35" />
<cause idref="E20" />
<clue>Inhibition of TF induction in the presence of high CsA blood concentrations was also observed <linkCause>when</linkCause> stimulation of cells was performed with interferon-gamma or interleukin-1beta.</clue>
<comment>NO CLUETYPE</comment>
</event>
<sentence id="S8">As shown by <term sem="Other" id="T50" lex="reverse_transcription-polymerase_chain_reaction">reverse transcription-polymerase chain reaction</term> and <term sem="Other" id="T51" lex="electrophoretic_mobility_shift_assay">electrophoretic mobility shift assay</term>, respectively, treatment with <term sem="Organic_compound_other" id="T52" lex="CsA">CsA</term> leads to decreased <term sem="Other" id="T53" lex="TF_mRNA_expression"><term sem="RNA_molecule" id="T54" lex="TF_mRNA"><term sem="Protein_family_or_group" id="T55" lex="TF">TF</term> mRNA</term> expression</term> and reduced activation of the <term sem="Protein_complex" id="T56" lex="NF-kappaB_transcription_factor"><term sem="Protein_complex" id="T57" lex="NF-kappaB">NF-kappaB</term> transcription factor</term>, which is known to contribute to the induction of the <term sem="DNA_domain_or_region" id="T58" lex="TF_promotor"><term sem="Protein_family_or_group" id="T59" lex="TF">TF</term> promotor</term> in <term sem="Cell_natural" id="T60" lex="human_monocyte">human <term sem="Cell_natural" id="T61" lex="monocyte">monocytes</term></term>.</sentence>
<event id="E23">
<type class="Transcription" />
<theme idref="T54" />
<clue>As shown by reverse transcription-polymerase chain reaction and electrophoretic mobility shift assay, respectively, treatment with CsA leads to decreased TF mRNA <clueType>expression</clueType> and reduced activation of the NF-kappaB transcription factor, which is known to contribute to the induction of the TF promotor in human monocytes.</clue>
</event>
<event id="E24">
<type class="Positive_regulation" />
<theme idref="T56" />
<clue>As shown by reverse transcription-polymerase chain reaction and electrophoretic mobility shift assay, respectively, treatment with CsA leads to decreased TF mRNA expression and reduced <clueType>activation</clueType> <linkTheme>of</linkTheme> the NF-kappaB transcription factor, which is known to contribute to the induction of the TF promotor in human monocytes.</clue>
</event>
<event id="E41">
<type class="Artificial_process" />
<theme idref="T52" />
<clue>As shown by reverse transcription-polymerase chain reaction and electrophoretic mobility shift assay, respectively, <clueType>treatment</clueType> <linkTheme>with</linkTheme> CsA leads to decreased TF mRNA expression and reduced activation of the NF-kappaB transcription factor, which is known to contribute to the induction of the TF promotor in human monocytes.</clue>
</event>
<event id="E25">
<type class="Negative_regulation" />
<theme idref="E23" />
<cause idref="E41" />
<clue>As shown <clueExperiment>by reverse transcription-polymerase chain reaction</clueExperiment> and electrophoretic mobility shift assay, respectively, treatment with CsA leads to <clueType>decreased</clueType> TF mRNA expression and reduced activation of the NF-kappaB transcription factor, which is known to contribute to the induction of the TF promotor in human monocytes.</clue>
</event>
<event id="E26">
<type class="Negative_regulation" />
<theme idref="E24" />
<cause idref="E41" />
<clue>As shown <clueExperiment>by</clueExperiment> reverse transcription-polymerase chain reaction and <clueExperiment>electrophoretic mobility shift assay</clueExperiment>, respectively, treatment with CsA leads to decreased TF mRNA expression and <clueType>reduced</clueType> activation of the NF-kappaB transcription factor, which is known to contribute to the induction of the TF promotor in human monocytes.</clue>
</event>
<event id="E27">
<type class="Positive_regulation" />
<theme idref="T58" />
<clue>As shown by reverse transcription-polymerase chain reaction and electrophoretic mobility shift assay, respectively, treatment with CsA leads to decreased TF mRNA expression and reduced activation of the NF-kappaB transcription factor, which is known to contribute to the <clueType>induction</clueType> <linkTheme>of</linkTheme> the TF promotor <clueLoc>in human monocytes</clueLoc>.</clue>
</event>
<event id="E39">
<type class="Positive_regulation" />
<theme idref="E27" />
<cause idref="T56" />
<clue>As shown by reverse transcription-polymerase chain reaction and electrophoretic mobility shift assay, respectively, treatment with CsA leads to decreased TF mRNA expression and reduced activation of the NF-kappaB transcription factor, which is known to <clueType>contribute</clueType> <linkTheme>to</linkTheme> the induction of the TF promotor in human monocytes.</clue>
</event>
<sentence id="S9">CONCLUSIONS: This study demonstrates that <term sem="Other" id="T62" lex="TF_activation"><term sem="Protein_family_or_group" id="T77" lex="TF">TF</term> activation</term>, occurring in <term sem="Cell_natural" id="T64" lex="mononuclear_cell">mononuclear cells</term> of <term sem="Multicellular_organism_natural" id="T65" lex="cardiac_transplant_recipient">cardiac <term sem="Multicellular_organism_natural" id="T66" lex="transplant_recipient">transplant recipients</term></term>, is inhibited by treatment with <term sem="Organic_compound_other" id="T67" lex="CsA">CsA</term>.</sentence>
<event id="E28">
<type class="Negative_regulation" />
<theme idref="E36" />
<cause idref="T67" />
<clue>CONCLUSIONS: This study demonstrates that TF activation, occurring <clueLoc>in mononuclear cells of cardiac transplant recipients</clueLoc>, is <clueType>inhibited</clueType> <linkCause>by</linkCause> treatment with CsA.</clue>
</event>
<event id="E36">
<type class="Positive_regulation" />
<theme idref="T77" />
<clue>CONCLUSIONS: This study demonstrates that TF <clueType>activation</clueType>, occurring in mononuclear cells of cardiac transplant recipients, is inhibited by treatment with CsA.</clue>
<comment>NER: T41 id mod, duplicated -&gt; T77</comment>
</event>
<sentence id="S10">Inhibition of <term sem="Other" id="T68" lex="monocyte_TF_induction"><term sem="Cell_natural" id="A9">monocyte</term> <term sem="Protein_family_or_group" id="T69" lex="TF">TF</term> induction</term> by <term sem="Organic_compound_other" id="T70" lex="CsA">CsA</term> may contribute to its successful use in <term sem="Organic_compound_other" id="T71" lex="cardiac_transplant_medicine">cardiac transplant medicine</term> and might be useful in managing further settings of <term sem="Other" id="T72" lex="vascular_pathology">vascular pathology</term> also known to involve <term sem="Other" id="T73" lex="TF_expression"><term sem="Protein_family_or_group" id="T74" lex="TF">TF</term> expression</term> and <term sem="Other" id="T75" lex="NF-kappaB_activation"><term sem="Protein_complex" id="T76" lex="NF-kappaB">NF-kappaB</term> activation</term>.</sentence>
<event id="E29">
<type class="Negative_regulation" />
<theme idref="E37" />
<cause idref="T70" />
<clue><clueType>Inhibition</clueType> <linkTheme>of</linkTheme> monocyte TF induction <linkCause>by</linkCause> CsA may contribute to its successful use in cardiac transplant medicine and might be useful in managing further settings of vascular pathology also known to involve TF expression and NF-kappaB activation.</clue>
</event>
<event id="E37">
<type class="Positive_regulation" />
<theme idref="T69" />
<cause idref="A9" />
<clue>Inhibition of <clueLoc>monocyte</clueLoc> TF <clueType>induction</clueType> by CsA may contribute to its successful use in cardiac transplant medicine and might be useful in managing further settings of vascular pathology also known to involve TF expression and NF-kappaB activation.</clue>
</event>
<event id="E30">
<type class="Correlation" />
<theme idref="T72" />
<theme idref="E38" />
<clue>Inhibition of monocyte TF induction by CsA may contribute to its successful use in cardiac transplant medicine and might be useful in managing further settings of vascular pathology also known to <clueType>involve</clueType> TF expression and NF-kappaB activation.</clue>
</event>
<event id="E38">
<type class="Gene_expression" />
<theme idref="T74" />
<clue>Inhibition of monocyte TF induction by CsA may contribute to its successful use in cardiac transplant medicine and might be useful in managing further settings of vascular pathology also known to involve TF <clueType>expression</clueType> and NF-kappaB activation.</clue>
</event>
<event id="E31">
<type class="Correlation" />
<theme idref="T72" />
<theme idref="E32" />
<clue>Inhibition of monocyte TF induction by CsA may contribute to its successful use in cardiac transplant medicine and might be useful in managing further settings of vascular pathology also known to <clueType>involve</clueType> TF expression and NF-kappaB activation.</clue>
</event>
<event id="E32">
<type class="Positive_regulation" />
<theme idref="T76" />
<clue>Inhibition of monocyte TF induction by CsA may contribute to its successful use in cardiac transplant medicine and might be useful in managing further settings of vascular pathology also known to involve TF expression and NF-kappaB <clueType>activation</clueType>.</clue>
</event>
</AbstractText>
</Abstract>
</Article>
</MedlineCitation>
</PubmedArticle>
</PubmedArticleSet>
</Annotation>
